Ms. Kim Whittemore reports

CALLITAS HEALTH ENGAGES DR. LAURA BERMAN, WORLD-RENOWNED SEX EDUCATOR, RESEARCHER AND THERAPIST AS CHIEF HEALTH ADVISOR

Dr. Laura Berman has joined the Callitas Health Inc. team. She will fill the role of chief health adviser, promoting ToConceive and providing insight and consultation on the development of the company's other products, both over-the-counter and the prescription drug under development for female sexual dysfunction, Extrinsa.

Dr. Berman is a world-renowned sex and relationship educator, researcher and therapist, as well as TV, radio and Internet host, presenting the weeknight radio program "Uncovered with Dr. Laura Berman." She's a New York Times bestselling author on sexual health and pleasure. Dr. Berman also acts as assistant clinical professor of OBGYN and psychiatry at the Feinberg School of Medicine at Northwestern University in Chicago.

The addition of Dr. Berman to the Callitas team emphasizes the company's commitment to female health and wellness and the importance of ToConceive, Extrinsa, and future sexual health and wellness products to the women's health sphere. "Dr. Berman is one of the most recognized and respected experts and a pioneer in women's sexual health," said Kim Whittemore, women's health advocate and Callitas board member. "She brings unparalleled reach and credibility to the Callitas products."

About Callitas Health Inc.

Formed in early 2015, Callitas Health is a clinical-stage company developing innovative technologies for obesity, weight management, and female health and wellness. In addition to its recent acquisitions of C-103, a reformulation of Orlistat, Extrinsa and assets from 40J's LLC, the company successfully launched ToConceive in North America as a clinically proven option for couples struggling with the inability to conceive.

We seek Safe Harbor.